1. At a Glance
India’s enzyme emperor has woken up after years of slow fermentation. Advanced Enzyme Technologies Ltd (AETL) reported Q2 FY26 revenue of ₹1,845 mn (₹184.5 Cr) and PAT ₹447 mn (₹44.7 Cr), clocking a sharp +26 % YoY revenue and +34 % YoY profit growth. Market-cap: ₹3,691 Cr, CMP ₹330, P/E 25×, Book Value ₹133, Dividend Yield 1.6 %.
Operating margin? 30.8 %. Debt? Barely ₹35 Cr — less than what most biotech labs spend on gloves.
Return on equity at 9.5 %, ROCE 13.1 %, Current Ratio 8.75 — a balance sheet so squeaky clean it could double as a sanitizer.
As the Bible says, “Faith by itself, if it does not have works, is dead.” And AETL has finally started showing some works — and profits — after years of staying flat like a petri dish in storage.
2. Introduction – From Powdered Science to Profitable Alchemy
For years, Advanced Enzyme was that nerdy biotech stock in everyone’s watchlist — the one that never blew up nor blew out. It was always “potential loading… please wait.” Founded by Vasant Rathi and family, this Thane-based enzyme house quietly built a global network spanning 45 countries and 700 customers while most retail investors were busy googling “What is an enzyme?”
Enzymes are nature’s tiny workers that make industries run smoother — from digestive supplements to detergents, animal feed to breweries. AETL makes over 400 proprietary products developed from 68 enzyme and probiotic bases. Essentially, it’s the DJ mixing tracks for the chemical world.
And finally in FY26, the beat dropped. Growth rebounded, margins stayed fat, and the company even earned a CRISIL upgrade. For a biotech firm that used to crawl at 7 % sales CAGR over five years, this 26 % quarterly pop feels like caffeine in a culture medium.
3. Business Model – WTF Do They Even Do?
Think of AETL as India’s bio-factory that sells “industrial stomach acid” to the world. Here’s the mix:
1️ Human Healthcare (68 %)
They supply enzymes and custom formulations to pharma and nutraceutical brands — the stuff that helps you digest your pizza and helps companies digest their P&L. Clients span North America, Europe, and Asia.
2️ Animal Nutrition (11 %)
Enzymes for poultry and swine feed — because even chickens deserve good gut health. It reduces feed costs for farmers and increases the “feel-good factor” for CSR reports.
3️ Industrial